1711 studies found for:    Alzheimer's disease
Show Display Options
Rank Status Study
1 Recruiting A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: NIC5-15;   Drug: Placebo
2 Active, not recruiting Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
Condition: Alzheimer's Disease
Interventions: Behavioral: Individualized management of AD including caregiver training;   Drug: Memantine
3 Withdrawn Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Procedure: fMRI to detect MCI patients who will convert to Alzheimer's disease
4 Completed
Has Results
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg;   Biological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 200 mg/kg;   Biological: Placebo solution: Human Albumin 0.25% - 4 mL/kg;   Biological: Placebo solution: Human Albumin 0.25% - 2 mL/kg
5 Active, not recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
6 Unknown  Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF;   Procedure: Placebo Surgery
7 Completed
Has Results
Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo
Condition: Alzheimer's Disease
Interventions: Drug: LY450139;   Drug: Placebo
8 Unknown  Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: donepezil
9 Recruiting Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Biological: Clinic and neuropsychologic evaluation;   Radiation: MRI;   Procedure: PET;   Biological: Apolipoprotein E genotyping;   Biological: Study of cerebrospinal fluid
10 Completed Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)
Condition: Alzheimer's Disease
Intervention:
11 Unknown  What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate?
Condition: Alzheimer Disease
Intervention: Other: neuropsychological assessment
12 Completed
Has Results
Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Varenicline;   Drug: Placebo
13 Active, not recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease
Intervention:
14 Active, not recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 150 mg/day;   Drug: TRx0237 250 mg/day;   Drug: Placebo
15 Completed Resveratrol for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol;   Drug: Placebo
16 Not yet recruiting Omental Transposition Surgery for Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Procedure: Omental transposition for mild Alzheimers disease
17 Recruiting Hearing Instruments in Alzheimer's Disease
Conditions: Alzheimer Disease;   Hearing Loss
Interventions: Device: Standard audiologic rehabilitation (incl. HI);   Device: Activity tracker
18 Unknown  Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin for Injection;   Drug: Placebo
19 Completed Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases;   Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
20 Recruiting Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care
Conditions: Alzheimers Disease;   Postoperative Delirium;   Post Operative Cognitive Dysfunction
Interventions: Drug: Total intravenous anesthesia with propofol;   Drug: General anesthesia with isoflurane

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years